Walleye Capital’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-600
Closed -$188K 4872
2025
Q2
$188K Buy
+600
New +$180K ﹤0.01% 3408
2024
Q3
Sell
-10,900
Closed -$4.49M 5650
2024
Q2
$4.49M Buy
10,900
+7,700
+241% +$3.05M 0.01% 1366
2024
Q1
$1.29M Buy
3,200
+400
+14% +$141K ﹤0.01% 2340
2023
Q4
$858K Sell
2,800
-1,700
-38% -$459K ﹤0.01% 2485
2023
Q3
$1.09M Buy
+4,500
New +$1.15M ﹤0.01% 2182
2023
Q2
Sell
-100
Closed -$18.8K 4654
2023
Q1
$18.8K Sell
100
-2,000
-95% -$414K ﹤0.01% 3413
2022
Q4
$446K Buy
+2,100
New +$420K 0.01% 1528

Other funds holding MEDP

Walleye Capital's MEDP Position: Q1 2026 in Review

Walleye Capital reduced its Medpace (MEDP) stake by 35% in Q1 2026, selling an estimated $1.62M and leaving 5,995 shares worth $2.88M. The position accounts for 0.01% of the portfolio, ranked #1180.

Walleye Capital first reported a position in MEDP in Q3 2021 and has held it in 8 quarters since. The position peaked at $5.14M in Q4 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Walleye Capital held 5,995 shares of Medpace worth $2.88M as of Q1 2026.
  • Walleye Capital sold 3,162 Medpace shares in Q1 2026, an estimated $1.62M.
  • Medpace made up 0.01% of Walleye Capital's portfolio in Q1 2026, its #1180 holding.
  • Walleye Capital first reported a position in Medpace in Q3 2021 and has held it in 8 quarters since.
  • Walleye Capital's Medpace position peaked at $5.14M in Q4 2025.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.